- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Toxic syrup tragedy: MP police hunt pharma co owner after child deaths

Bhopal: A massive manhunt is underway as Madhya Pradesh police have dispatched a team to Chennai and Kanchipuram to arrest the owner of Sresan Pharma, the manufacturer of the toxic Coldrif cough syrup linked to the deaths of children.
The syrup, reportedly laced with kidney-damaging toxin chemicals, has sparked outrage across the state, with three more children succumbing to renal complications in the past 24 hours.
The death toll now stands at 20, with 17 from Chhindwara, one from Pandhurna, and two from Betul. Doctors said five more children remain critically ill in Nagpur.
The deceased include Dhani Deharia (1.5 years) from Tamia, Jyanshu Yaduvanshi (2 years) from Junnardev, and Vedansh Pawar (2.5 years) from Ridhora. All were undergoing treatment in Nagpur hospitals.
As per IANS, Deputy Chief Minister Rajendra Shukla, speaking to media in Chhindwara on Wednesday, confirmed the development and assured that the government is taking all necessary steps to ensure justice.
"A police team from Chhindwara has been sent to Chennai and Kanchipuram to arrest the owner of the company which manufactures 'Coldrif' cough syrup," he stated.
Medical investigations have revealed that the Coldrif syrup contained toxic chemicals that severely damaged the kidneys of the children.
Within hours of consumption, symptoms of renal failure began to appear, leading to rapid deterioration in their health.
The Chhindwara district administration has intensified its response, sealing five medical stores and sending syrup samples for laboratory testing.
Public announcements are being made in villages, warning parents against administering any cough syrup to children.
Meanwhile, the Indian Medical Association (IMA) has expressed concern over the alleged wrongful implication of doctors in the case.
Some private practitioners, including Praveen Soni, are under scrutiny for prescribing or administering the syrup.
The IMA has threatened to go on strike, prompting Deputy CM Shukla to urge restraint.
"Doctors should not go on strike and must follow the Union government's advisory against prescribing cold syrups to children below four years," he said.
Political reactions have been swift. The Congress has demanded Rs 1 crore compensation for each affected family and accused the government of negligence.
The BJP has maintained that the investigation is being conducted transparently and assured that those responsible will be held accountable.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751